Publications | UK Covid Vaccine Research Hub

Filter by:

Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis

Multiple Sclerosis and Related Disorders

12th December 2022

Novel Coronavirus SARS-CoV-2

Patient and public involvement in COVID-19 research: bridging the gap between theory and practice

12th December 2022

PPI report title card

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom

The Lancet - Regional Health

11th December 2022

Novel Coronavirus SARS-CoV-2

Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case–control study

The Lancet - Regional Health

7th December 2022

Novel Coronavirus SARS-CoV-2

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prosp

The Lancet - Gastroenterology & Hepatology

5th December 2022

Novel Coronavirus SARS-CoV-2

The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as A Case Study

MedRxiv

4th December 2022

Novel Coronavirus SARS-CoV-2

Correlates of protection against SARS-CoV-2 Omicron variant and anti-spike antibody responses after a third/booster vaccination or breakthrough infection in the UK general population

MedRxiv

30th November 2022

Novel Coronavirus SARS-CoV-2

Prediction of Covid-19 vaccine effectiveness in adult populations and in clinically-vulnerable subgroups

MedRxiv

25th November 2022

Novel Coronavirus SARS-CoV-2

Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negativ

The Lancet - Infectious Diseases

24th November 2022

Novel Coronavirus SARS-CoV-2